870 related articles for article (PubMed ID: 17034579)
21. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
[TBL] [Abstract][Full Text] [Related]
22. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C therapy with interferon-α and ribavirin reduces the CD4 cell count and the total, 2LTR circular and integrated HIV-1 DNA in HIV/HCV co-infected patients.
Jiao YM; Weng WJ; Gao QS; Zhu WJ; Cai WP; Li LH; Li HJ; Gao YQ; Wu H
Antiviral Res; 2015 Jun; 118():118-22. PubMed ID: 25823618
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study.
Tural C; Solà R; Rubio R; Santín M; Planas R; Quereda C; Berenguer J; Montes-Ramírez M; Clotet B;
J Viral Hepat; 2007 Oct; 14(10):704-13. PubMed ID: 17875005
[TBL] [Abstract][Full Text] [Related]
25. Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells.
Yin L; Rodriguez CA; Hou W; Potter O; Caplan MJ; Goodenow MM; Sleasman JW
J Allergy Clin Immunol; 2008 Jul; 122(1):166-72, 172.e1-2. PubMed ID: 18538835
[TBL] [Abstract][Full Text] [Related]
26. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus.
Hammond T; Lee S; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P
Cell Immunol; 2010; 264(2):150-5. PubMed ID: 20579979
[TBL] [Abstract][Full Text] [Related]
28. Characterizing immune reconstitution after long-term highly active antiretroviral therapy in pediatric AIDS.
Resino S; Correa R; Bellón JM; Sánchez-Ramón S; Muñoz-Fernández MA
AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1395-406. PubMed ID: 12487811
[TBL] [Abstract][Full Text] [Related]
29. Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA+ and CD45RO+ T lymphocyte subpopulations.
Nokta M; Rossero R; Nichols J; Rosenbaum M; Pollard RB
AIDS Res Hum Retroviruses; 1999 Feb; 15(3):255-64. PubMed ID: 10052756
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of T cell receptor gene rearrangement excision circles after antiretroviral therapy in children infected with human immunodeficiency virus.
Chavan S; Bennuri B; Kharbanda M; Chandrasekaran A; Bakshi S; Pahwa S
J Infect Dis; 2001 May; 183(10):1445-54. PubMed ID: 11329124
[TBL] [Abstract][Full Text] [Related]
31. CD4+ and CD8+ T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents.
Pahwa S; Chitnis V; Mitchell RM; Fernandez S; Chandrasekharan A; Wilson CM; Douglas SD
AIDS Res Hum Retroviruses; 2003 Jun; 19(6):487-95. PubMed ID: 12882658
[TBL] [Abstract][Full Text] [Related]
32. The Changed Proportion of CD45RA
Hsiao JL; Ko WS; Shih CJ; Chiou YL
J Interferon Cytokine Res; 2017 Jul; 37(7):303-309. PubMed ID: 28414566
[TBL] [Abstract][Full Text] [Related]
33. T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV-infected and HIV-uninfected individuals.
Steffens CM; Smith KY; Landay A; Shott S; Truckenbrod A; Russert M; Al-Harthi L
AIDS; 2001 Sep; 15(14):1757-64. PubMed ID: 11579236
[TBL] [Abstract][Full Text] [Related]
34. Open, randomized, multicentre italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART.
Cargnel A; Angeli E; Mainini A; Gubertini G; Giorgi R; Schiavini M; Duca P;
Antivir Ther; 2005; 10(2):309-17. PubMed ID: 15865225
[TBL] [Abstract][Full Text] [Related]
35. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
Bräu N
Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
[TBL] [Abstract][Full Text] [Related]
36. CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment.
Legrand E; Neau D; Galperine T; Trimoulet P; Moreau JF; Pitard V; Lacut JY; Ragnaud JM; Dupon M; Le Bail B; Bernard N; Schvoerer E; Houghton M; Fleury H; Lafon ME
J Infect Dis; 2002 Aug; 186(3):302-11. PubMed ID: 12134226
[TBL] [Abstract][Full Text] [Related]
37. Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.
Núñez M; Miralles C; Berdún MA; Losada E; Aguirrebengoa K; Ocampo A; Arazo P; Cervantes M; de Los Santos I; San Joaquín I; Echeverría S; Galindo MJ; Asensi V; Barreiro P; Sola J; Hernandez-Burruezo JJ; Guardiola JM; Romero M; García-Samaniego J; Soriano V;
AIDS Res Hum Retroviruses; 2007 Aug; 23(8):972-82. PubMed ID: 17725413
[TBL] [Abstract][Full Text] [Related]
38. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
[TBL] [Abstract][Full Text] [Related]
39. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
Najafi Fard S; Schietroma I; Corano Scheri G; Giustini N; Serafino S; Cavallari EN; Pinacchio C; De Girolamo G; Ceccarelli G; Scagnolari C; Vullo V; d'Ettorre G
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):319-329. PubMed ID: 29279268
[TBL] [Abstract][Full Text] [Related]
40. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
